MREOVSMXCT• 6 Months (Normalized)
MREO vs MXCT (Mereo BioPharma Group plc vs MaxCyte Inc.)
Showing Closing Date Range from Mar, 20 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
MREO Performance $0.27
-22.22%
Mereo BioPharma Group plc
Normalized Baseline0.00%
MXCT Performance $1.18
+54.25%
MaxCyte Inc.
Normalized Baseline0.00%
Alpha Spread Margin MXCT LEADS
-76.47%
MXCT outperforming by 76.47%
MREOMXCT
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
MREO MXCT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | MREO Price | MREO Gain (%) | MXCT Price | MXCT Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $0.27 | -22.22% | $1.18 | +54.25% | -76.47% |
| Sep 15, 2026 | $0.29 | -16.67% | $1.19 | +55.56% | -72.23% |
| Sep 14, 2026 | $0.28 | -18.13% | $1.18 | +53.59% | -71.72% |
| Sep 11, 2026 | $0.28 | -18.13% | $1.16 | +51.63% | -69.76% |
| Sep 10, 2026 | $0.25 | -28.36% | $1.19 | +55.56% | -83.92% |
| Sep 09, 2026 | $0.24 | -28.95% | $1.22 | +59.48% | -88.43% |
| Sep 08, 2026 | $0.26 | -25.44% | $1.28 | +66.67% | -92.11% |
| Sep 04, 2026 | $0.25 | -26.90% | $1.28 | +67.32% | -94.22% |
| Sep 03, 2026 | $0.27 | -20.47% | $1.26 | +64.71% | -85.18% |
| Sep 02, 2026 | $0.27 | -21.93% | $1.27 | +66.01% | -87.94% |
| Sep 01, 2026 | $0.28 | -19.01% | $1.24 | +62.09% | -81.10% |
| Aug 31, 2026 | $0.27 | -21.93% | $1.29 | +68.63% | -90.56% |
| Aug 28, 2026 | $0.25 | -26.02% | $1.22 | +59.48% | -85.50% |
| Aug 27, 2026 | $0.27 | -20.47% | $1.28 | +67.32% | -87.79% |
| Aug 26, 2026 | $0.28 | -18.71% | $1.31 | +71.24% | -89.95% |
Page 1 of 9